Federal award
BLOODWORKS
HT941024P0103
Contract
Obligated and Ceiling
- Obligated (net)
- $160,221.27
- Ceiling (potential value, not spending)
- $1,613,161.06
- Current value
- $543,210.06
- Gross positive obligations
- $787,831.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- BLOODWORKS · ZN56PFWUDQK7
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- BLOODWORKS · ZN56PFWUDQK7
- Awarding agency
- Department of War · sub-agency 97DH · office HT9410
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- HT941024P0103
- Award type code
- B
- Actions
- 9 · Feb 27, 2024 to Dec 31, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 31, 2025 | FY2026 | P00010 | B | −$183,026.80 | — |
| Sep 11, 2025 | FY2025 | P00009 | B | −$314,582.93 | — |
| Jul 29, 2025 | FY2025 | P00008 | B | −$130,000.00 | — |
| Jul 8, 2025 | FY2025 | P00007 | B | $0.00 | — |
| Jan 28, 2025 | FY2025 | P00006 | C | $265,191.00 | — |
| Nov 21, 2024 | FY2025 | P00003 | B | $205,601.00 | — |
| Sep 12, 2024 | FY2024 | P00002 | B | $0.00 | — |
| Apr 18, 2024 | FY2024 | P00001 | B | $207,800.00 | — |
| Feb 27, 2024 | FY2024 | 0 | — | $109,239.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.